UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Consensus on validation of forensic voice comparison

Science & justice, 2021-05, Vol.61 (3), p.299-309

2021

Volltextzugriff (PDF)

Cigarette Smoking and Irinotecan Treatment: Pharmacokinetic Interaction and Effects on Neutropenia

Journal of clinical oncology, 2007-07, Vol.25 (19), p.2719-2726

2007

Volltextzugriff (PDF)

The "Liver-First Approach" for Patients with Locally Advanced Rectal Cancer and Synchronous Liver Metastases

Diseases of the colon & rectum, 2009-01, Vol.52 (1), p.23-30

2009

Volltextzugriff (PDF)

Safety and efficacy of induced sputum in young children hospitalised with suspected pulmonary tuberculosis

The international journal of tuberculosis and lung disease, 2014-01, Vol.18 (1), p.8-12

2014

Volltextzugriff (PDF)

A multicentre phase I and pharmacokinetic study of BN80915 (diflomotecan) administered daily as a 20-min intravenous infusion for 5 days every 3 weeks to patients with advanced solid tumours

Annals of oncology, 2007-03, Vol.18 (3), p.569-575

2007

Volltextzugriff (PDF)

Prophylaxis of Irinotecan‐Induced Diarrhea with Neomycin and Potential Role for UGT1A128 Genotype Screening: A Double‐Blind, Randomized, Placebo‐Controlled Study

The oncologist (Dayton, Ohio), 2006-09, Vol.11 (8), p.944-954

2006

Volltextzugriff (PDF)

A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumors

Cancer chemotherapy and pharmacology, 2005, Vol.55 (1), p.91-99

2005

Volltextzugriff (PDF)

A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours

British Journal of Cancer, 2000-07, Vol.83 (1), p.22-29

2000

Volltextzugriff (PDF)

Reduced striatal dopamine D2/3 receptor availability in Body Dysmorphic Disorder

European neuropsychopharmacology, 2016-02, Vol.26 (2), p.350-356

2016

Volltextzugriff (PDF)

Phase I and Pharmacologic Study of PKI166, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients with Advanced Solid Malignancies

Clinical cancer research, 2005-10, Vol.11 (19), p.6908-6915

2005

Volltextzugriff (PDF)

Preoperative chemoradiation with capecitabine in locally advanced rectal cancer

Netherlands journal of medicine, 2008-02, Vol.66 (2), p.71

2008

Volltextzugriff (PDF)

A CYP3A4 Phenotype–Based Dosing Algorithm for Individualized Treatment of Irinotecan

Clinical cancer research, 2010-01, Vol.16 (2), p.736-742

2010

Volltextzugriff (PDF)

Phase I Pharmacologic Study of Oral Topotecan and Intravenous Cisplatin: Sequence-Dependent Hematologic Side Effects

Journal of clinical oncology, 2000-05, Vol.18 (10), p.2104-2115

2000

Volltextzugriff (PDF)

Relationship between the exposure to cisplatin, DNA-adduct formation in leucocytes and tumour response in patients with solid tumours

British journal of cancer, 1996-06, Vol.73 (12), p.1569-1575

1996

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of the Polyamine Synthesis Inhibitor SAM486A in Combination with 5-Fluorouracil/ Leucovorin in Metastatic Colorectal Cancer

Clinical cancer research, 2004-03, Vol.10 (6), p.1949-1955

2004

Volltextzugriff (PDF)

Weekly oral paclitaxel as first-line treatment in patients with advanced gastric cancer

Annals of oncology, 2003-02, Vol.14 (2), p.197-204

2003

Volltextzugriff (PDF)

The potential of statins as part of anti-cancer treatment

European journal of cancer (1990), 2005-03, Vol.41 (4), p.516-522

2005

Volltextzugriff (PDF)

Phase I and pharmacologic study of oral topotecan administered twice daily for 21 days to adult patients with solid tumors

Journal of clinical oncology, 1997-03, Vol.15 (3), p.1087-1093

1997

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of Brostallicin (PNU-166196), a New DNA Minor-Groove Binder, Administered Intravenously Every 3 Weeks to Adult Patients with Metastatic Cancer

Clinical cancer research, 2003-08, Vol.9 (8), p.2957-2964

2003

Volltextzugriff (PDF)

Phase I and pharmacologic study of docetaxel and cisplatin in patients with advanced solid tumors

Journal of clinical oncology, 1997-03, Vol.15 (3), p.1071-1079

1997

Volltextzugriff (PDF)

A Comparison of Clinical Pharmacodynamics of Different Administration Schedules of Oral Topotecan (Hycamtin)

Clinical cancer research, 1999-01, Vol.5 (1), p.69-75

1999

Volltextzugriff (PDF)

Phase I Study of 3-Week Schedule of Irinotecan Combined With Cisplatin in Patients With Advanced Solid Tumors

Journal of clinical oncology, 2000-01, Vol.18 (1), p.187-194

2000

Volltextzugriff (PDF)

Phase II and pharmacologic study of topotecan administered as a 21-day continuous infusion to patients with colorectal cancer

Journal of clinical oncology, 1996-09, Vol.14 (9), p.2540-2545

1996

Volltextzugriff (PDF)

Simple prognostic model to predict survival in patients with undifferentiated carcinoma of unknown primary site

Journal of clinical oncology, 1995-07, Vol.13 (7), p.1720-1725

1995

Volltextzugriff (PDF)

Body-Surface Area–Based Dosing Does Not Increase Accuracy of Predicting Cisplatin Exposure

Journal of clinical oncology, 2001-09, Vol.19 (17), p.3733-3739

2001

Volltextzugriff (PDF)

1 – 25 von 272

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(220)
Mit Volltextzugriff
(241)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(130)
Science & Technology
(127)
Life Sciences & Biomedicine
(121)
Female
(108)
Middle Aged
(107)
Male
(103)
Adult
(100)
Aged
(99)
Biological And Medical Sciences
(94)
Medical Sciences
(91)
Oncology
(90)
Pharmacology. Drug Treatments
(79)
Antineoplastic Agents
(73)
Chemotherapy
(71)
Neoplasms - Drug Therapy
(39)
Drug Administration Schedule
(31)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(30)
Cisplatin - Administration & Dosage
(27)
Dose-Response Relationship, Drug
(26)
Infusions, Intravenous
(26)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Consensus on validation of forensic voice comparison

Cigarette Smoking and Irinotecan Treatment: Pharmacokinetic Interaction and Effects on Neutropenia

The "Liver-First Approach" for Patients with Locally Advanced Rectal Cancer and Synchronous Liver Metastases

Safety and efficacy of induced sputum in young children hospitalised with suspected pulmonary tuberculosis

A multicentre phase I and pharmacokinetic study of BN80915 (diflomotecan) administered daily as a 20-min intravenous infusion for 5 days every 3 weeks to patients with advanced solid tumours

Prophylaxis of Irinotecan‐Induced Diarrhea with Neomycin and Potential Role for UGT1A128 Genotype Screening: A Double‐Blind, Randomized, Placebo‐Controlled Study

A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumors

A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours

Reduced striatal dopamine D2/3 receptor availability in Body Dysmorphic Disorder

Phase I and Pharmacologic Study of PKI166, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients with Advanced Solid Malignancies

Preoperative chemoradiation with capecitabine in locally advanced rectal cancer

A CYP3A4 Phenotype–Based Dosing Algorithm for Individualized Treatment of Irinotecan

Phase I Pharmacologic Study of Oral Topotecan and Intravenous Cisplatin: Sequence-Dependent Hematologic Side Effects

Relationship between the exposure to cisplatin, DNA-adduct formation in leucocytes and tumour response in patients with solid tumours

Phase I and Pharmacokinetic Study of the Polyamine Synthesis Inhibitor SAM486A in Combination with 5-Fluorouracil/ Leucovorin in Metastatic Colorectal Cancer

Weekly oral paclitaxel as first-line treatment in patients with advanced gastric cancer

The potential of statins as part of anti-cancer treatment

Phase I and pharmacologic study of oral topotecan administered twice daily for 21 days to adult patients with solid tumors

Phase I and Pharmacokinetic Study of Brostallicin (PNU-166196), a New DNA Minor-Groove Binder, Administered Intravenously Every 3 Weeks to Adult Patients with Metastatic Cancer

Phase I and pharmacologic study of docetaxel and cisplatin in patients with advanced solid tumors

A Comparison of Clinical Pharmacodynamics of Different Administration Schedules of Oral Topotecan (Hycamtin)

Phase I Study of 3-Week Schedule of Irinotecan Combined With Cisplatin in Patients With Advanced Solid Tumors

Phase II and pharmacologic study of topotecan administered as a 21-day continuous infusion to patients with colorectal cancer

Simple prognostic model to predict survival in patients with undifferentiated carcinoma of unknown primary site

Body-Surface Area–Based Dosing Does Not Increase Accuracy of Predicting Cisplatin Exposure

Suchergebnisse filtern